Missed Out on Moderna? My Best Biotech Stock to Buy and Hold
Moderna (NASDAQ: MRNA) has seen its stock price soar nearly 800% over the past two years. That's after the biotech company brought its coronavirus vaccine to market and generated billions of dollars in revenue and profit. Those of you who bought the shares back in 2019 are probably cheering right now. But if you missed out on Moderna, you may be feeling a little glum. No need to.
There always are promising investment opportunities around. And right now, I'm excited about a biotech company that, like Moderna, generates billions of dollars in revenue and profit. It's actually been doing so for a while. And this company just so happens to be working on a program with... none other than Moderna. Let's take a close look at my best biotech stock to buy and hold.
Image source: Getty Images.
Source Fool.com
